Elite Pharmaceuticals Inc (OTCQB:ELTP)

0.245
Delayed Data
As of Apr 24
 +0.002 / +0.82%
Today’s Change
0.17
Today|||52-Week Range
0.51
+8.41%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Generic
MARKET CAP
$151.5M

Company Description

Elite Pharmaceuticals, Inc. is a pharmaceutical company, which is specialized in the development and manufacture of oral, controlled-release products, using proprietary know-how and technology, as it relates to abuse resistant products. The company strategy includes off-patent drug products for life cycle management and developing generic versions of controlled-release drug products. Elite Pharmaceuticals was founded on October 1, 1997 and is headquartered in Northvale, NJ.

Contact Information

Elite Pharmaceuticals, Inc.
165 Ludlow Avenue
Northvale New Jersey 07647
P:(201) 750-2646
Investor Relations:
(518) 398-6222

Employees

Shareholders

Individual stakeholders23.59%
Mutual fund holders0.18%
Other institutional0.02%

Top Executives

Nasrat A. HakimPresident, Chief Executive Officer & Director
Doug PlasscheExecutive Vice President-Operations
Carter J. WardChief Financial Officer, Secretary & Treasurer
Jason LepreeVice President-Scientific Affairs
Christopher C. DickHead-Development

To view my watchlist

Not a member yet?

Sign up now for a free account